Introduction
Aortic valve disease includes, aortic stenosis, aortic insufficiency, and mixed aortic valve disease, which are distinct pathologies leading to reduced survival. 1 -3 A stenosis of the aortic valve obstructs left-ventricular outflow leading to pressure-overload hypertrophy, exercise intolerance, and heart failure. Aortic insufficiency is a different condition. The haemodynamic problem is volume overload and unlike aortic stenosis, aortic insufficiency may develop either acutely or progressively over several years. Despite its importance, little is known about the contemporary clinical course and comparative prognostic significance of different types of aortic valve disease. 4 The public health burden of heart valve disease increases with age, 5, 6 and until recently, valve replacement was the only treatment which could improve prognosis. 7, 8 However, new treatment options are emerging. Transcatheter aortic valve implantation (TAVI) improves prognosis in inoperable patients when compared with standard medical care, 9 and in highrisk patients, outcomes after TAVI are similar to outcomes after surgical valve replacement. 10 For these reasons, information on In order to answer these questions, we studied contemporary information extracted from national databases for hospital admissions and deaths in Scotland with follow-up over a 10-year period.
Methods

Record linkage
We obtained data from the Information Services Division (ISD) of National Health Service (NHS) Scotland, an extract of linked data containing all hospitalization and mortality records of all patients in Scotland who have a hospitalization code for heart valve disease since 1981. The national record linkage scheme for discharges from Scottish hospitals and deaths 11, 12 has been used in other studies of cardiovascular epidemiology. 13, 14 In brief, the ISD of the NHS in Scotland collates data on all hospital discharges using the Scottish Morbidity Record Scheme (SMR01). These are then linked to the death records held by the General Register Office for Scotland. Diagnoses in the records are coded using the International Classification of Diseases codes (ICD9 or ICD10) and operations are coded using Office of Population, Censuses, and Surveys Classification of Surgical Operations and Procedures Fourth Revision (OPCS-4) codes.
Definitions of disease
Acquired aortic valve disease was taken to represent all forms of noncongenital heart disease. We identified the first report of aortic valve disease in a principal (primary) or secondary discharge diagnostic position with the following codes: I35 ['I350' (aortic stenosis), 'I351' (aortic insufficiency), 'I352' (aortic stenosis with insufficiency), 'I358' and 'I359' (other and unspecified aortic valve disease)] from ICD10. The diagnostic categories of aortic valve disease are available from ICD10 (but not ICD9). Aortic valve replacement was identified using OPCS-4 codes 'K261-K264' and 'K268'. Aortic valve replacement included elective or non-elective operations. Aortic balloon valvuloplasty was identified using OPCS-codes 'K265' and 'K352'.
Patients with congenital aortic valve disease (n ¼ 203, codes ICD-9 746, ICD10 Q22, Q23) and endocarditis (n ¼ 485, codes I011, I33, I38-I39) were excluded. Pulmonary and tricuspid valve disease was not studied since disease of these valves is strongly associated with congenital heart disease and pulmonary hypertension, respectively.
Data were available in the Scottish national databases from 1 January 1981 and complete records up to 31 December 2006 were obtained.
Our analyses are based on new incident cases of aortic valve disease from 1 January 1997, from which point all records are fully coded using ICD10. OPCS-4 included a code for aortic valve replacement. To ensure that all patients in our database had a minimum of 1 year of follow-up, we included all index cases up to 31 December 2005 and incorporated follow-up until 31 December 2006.
Co-morbidity and hospital admission history
We identified the baseline medical history from events prior to the index event, co-morbidities for the index event, and various individual and composite clinical outcomes and also outcomes for valve intervention by surgery or balloon valvuloplasty. Co-morbidity was defined as concomitant or prior diagnoses (within 5 years) of the index hospitalization with aortic valve disease for the following diseases: diabetes (ICD-10 codes E10 -E14); respiratory disease (J10-J18, J40-J47); cancer (C00 -C99); hypertension (I10); renal disease (N17 -N19); and rheumatoid arthritis (M05 -M06).
Cardiovascular hospitalization history was identified from cardiac diagnosis or procedures separately on whether they are concurrent or in a prior admission within 5 years of the index admission. Cardiovascular events during follow-up were also identified. The ICD-10 codes used to identify these events are listed in the Supplementary material online.
The following cardiac procedures were included: aortic valve replacement (OPCS-4 codes K261 -K264, K268), coronary artery bypass grafting (CABG) (OPCS-4 codes K401 -K404, K408 -K414, K418 -K419, K421 -K424, K428 -K429, K431-K434, K438 -K439, K441 -K442, K448 -K449, K451 -K456, K458-K459, K461 -K465, and K468 -K469; OPCS-3 codes 323 and 324), and percutaneous coronary intervention (PCI) (OPCS-4 codes K491 -K493, K498 -K499, K501 -K503, K508-K509, K511, and K518-K519).
Socio-economic status
Socio-economic status was determined using the Deprivation Category score. 11 This is an ordinal index of socio-economic status in Scotland based on the place of residence, as defined by postcode. The score includes contemporary census-based information on the percentage of the population within attributes related to poverty (e.g. % without a car, % subject to overcrowding, % male unemployment, and % low social class). The 5-point scale was recategorized for analysis as 1 (high socio-economic status/affluent, scores 1 -2) to 3 (low socio-economic status/most deprived, scores 4 -5).
Quality assurance
Quality assurance analyses of heart valve disease codes in our data set were performed using SMR01 data for 
Statistics
Continuous variables are summarized as mean (standard deviation) and categorical data as count (percentage). Time to event analyses were undertaken using Cox Proportional-Hazards models. Time was derived from the date of index admission to the date of the event; for those subjects not experiencing an event a censoring date of 31 December 2006 was used. Backwards selection was used to identify the independent predictors of events using the baseline characteristics Differences in time to event between aortic valve disease types were investigated using unadjusted and adjusted Cox-ProportionalHazards models. The unadjusted models included a covariate for disease type only and the adjusted models included all independent predictors identified from the backwards selection for each endpoint.
Incidence of aortic valve disease was age -sex standardized based on the age and sex distribution of the population in 2005. Incidence was presented as the standardized number of events per 1 million of the population. We also investigated the incidence of the specific types aortic valve disease within four age groups (,60, 60 -69, 70 -79, and over 80 years). We plotted the standardized incidence over time to investigate any trends over time.
Results
Patient characteristics and temporal trends in hospitalizations for each type of aortic valve disease in Scotland A total of 19 733 patients aged ≥18 years had an index hospitalization with a final diagnosis of aortic valve disease in a primary [n ¼ 5176 (26.2%)] or secondary diagnostic position [2nd-6th positions, n ¼ 14 557 (73.8% cases), Table 1 ] of the SMR01 record.
The average age at the time of a first presentation with aortic valve disease was 71 and 76 years in men and women, respectively. Age at first presentation differed between types of aortic valve disease ( Table 1 ) and patients with isolated aortic stenosis at first presentation were older than patients with other types of aortic valve disease. Although gender was not related to the type of aortic valve disease, deprivation and several co-morbidities were, including a history of diabetes, cancer, and renal disease which were more common in patients with aortic stenosis. History of rheumatoid arthritis was more common in patients with isolated aortic insufficiency ( Table 1) . The most common cardiovascular problem overall was heart failure which was a complicating factor in one quarter of all index admissions ( Table 1) . Atrial fibrillation or flutter occurred in nearly one-fifth of all index admissions and was most common in patients with aortic insufficiency.
The temporal trends in the incidences of different types of aortic valve disease are shown in Figure 1 . Figure 3 ) and the majority of these patients (71.6%) had aortic stenosis ( Table 2) . When compared with aortic stenosis, the likelihood of death was less with aortic insufficiency [hazard ratio (95% confidence interval) 0.79 (0.74, 0.84)] and mixed aortic valve . The independent predictors of subsequent all-cause mortality are described in Table 2 . Female gender, year of admission, and hypertension reduced the likelihood of mortality in patients with aortic stenosis. Deprivation increased the likelihood of mortality following a diagnosis of aortic stenosis.
Death or index rehospitalization for heart failure, myocardial infarction, or stroke according to aortic valve disease type Death or rehospitalization for heart failure A total of 10 604 (53.7%) deaths or index heart failure hospitalizations occurred (see Supplementary material online, Table S1 and Figure S1 ). Of these, 619 (5.8%) and 1961 (18.5%) subjects experienced a fatal or non-fatal hospital index admission with heart failure, respectively. When compared with other types of aortic valve disease, aortic stenosis increased the risk of death following a heart failure hospitalization (adjusted P , 0.001).
Death or rehospitalization for myocardial infarction or stroke
In total, 10 301 (52.2%) deaths or rehospitalization for myocardial infarction and 10 688 (54.2%) deaths or rehospitalization for stroke or transient ischaemic attack occurred (Supplementary material online, Figures S1 and S2, respectively) . Overall, a hospital admission for myocardial infarction was fatal in 38% of patients with aortic stenosis with or without insufficiency, whereas the fatality rate was much lower for hospitalization with stroke (18.8 and 20.3%, respectively) and for heart failure (24.8 and 28.9%, respectively) (Supplementary material online, Table S1 ).
When compared with other forms of aortic valve disease, aortic stenosis had a higher hazard ratio for time to death following myocardial infarction or stroke, although this was not significant after adjustment for age, year of admission, and co-morbidity (Supplementary material online, Table S2 ).
Aortic valve replacement according to the type of aortic valve disease
The first aortic valve replacement took place in 3 367 (19.4%) patients of whom 73.2% had aortic stenosis, 11.9% had an unspecified type of aortic valve disease, and 10.0% had aortic insufficiency and 4.9% had aortic stenosis with insufficiency ( Figure 4 and Table 3 ). Seven hundred and eighty patients had an aortic valve replacement during their index hospital admission. The likelihood of aortic valve replacement in patients with aortic stenosis (isolated or mixed) was reduced with female gender, co-morbidities (e.g. renal disease, respiratory disease), and concurrent myocardial infarction ( Table 3 ). In patients with aortic stenosis, the likelihood of aortic valve replacement increased with the year of admission and decreased with concurrent coronary artery bypass surgery and PCI.
Discussion
Our results provide insights into the distinct and changing course of different types of aortic valve disease in Scotland over a 10-year period.
Aortic stenosis was the commonest type of aortic valve disease and its incidence in Scotland has nearly doubled from 1997 to 2005. The rising incidence is mainly in elderly persons aged 80 and older. Our results identify the prognostic importance of aortic stenosis when compared with other types of aortic valve disease. Aortic stenosis conferred a higher risk of death, or death and heart failure when compared with other types of aortic valve disease. The fatality rate associated with a hospitalization for myocardial infarction was 38% which was approximately double the rate of death associated with a hospitalization for heart failure or for stroke. The cumulative incidence of aortic valve replacement has nearly doubled during the past 10 years and aortic stenosis with insufficiency was the commonest indication for surgery.
Our findings indicate a striking rising trend in hospitalizations for aortic valve disease in Scotland in recent years. This trend is most pronounced for aortic stenosis which appears to have a distinct clinical course. The possible reasons to explain this finding include a lower threshold for patients to seek medical care and improved diagnostic methods. One other important factor is increased longevity in the general population since degenerative aortic valve disease is much more common in the elderly. 6 There were notable differences in the characteristics of patients according to the type of aortic valve disease. Patients with aortic stenosis were older than patients with mixed aortic valve disease or isolated aortic insufficiency. Deprivation status also differed according to type of aortic valve disease and a higher proportion of patients with aortic stenosis (with or without insufficiency) Figure 3 Kaplan-Meier plot for all-cause mortality by type of aortic valve disease. The hazard ratios (95% confidence interval) for all-cause mortality for aortic insufficiency, aortic stenosis with insufficiency, and other/unspecified aortic valve disease compared with aortic stenosis are shown beneath the figure. Hazard ratios (95% confidence interval) are shown unadjusted and adjusted for other predictors of mortality ( Table 2) , including deprivation.
Increasing burden of aortic valve disease in Scotland were deprived. Heart failure was a common complicating problem, affecting a quarter of patients with either aortic stenosis, aortic insufficiency, or mixed aortic valve disease. Cancer was more common in aortic stenosis, perhaps because patients with this type of aortic valve disease were older.
Natural history following a diagnosis of aortic valve disease
Our findings point to differences in the health outcomes following a diagnosis of aortic stenosis, aortic insufficiency, or mixed aortic valve disease. When compared with other types of aortic valve disease, aortic stenosis conferred an increased risk of mortality or of adverse cardiovascular events including myocardial infarction, heart failure, and stroke. Year of admission reduced the likelihood of mortality in patients with aortic stenosis. One explanation for this finding could be earlier detection of aortic stenosis and the presence of less advanced cardiovascular health problems at the time of first hospitalization. We also found that deprivation increased the likelihood of mortality and cardiovascular morbidity following a diagnosis of aortic stenosis.
Our observations draw attention to the prognostic implications of aortic stenosis. When compared with other types of aortic valve disease, aortic stenosis was an independent predictor of all-cause mortality and of all-cause mortality plus heart failure hospitalization. We also observed that the mortality rate associated with a subsequent hospitalization for myocardial infarction was very high. The fatality rate with myocardial infarction was highest . ............ ............ ............ ............ ........... ............ ............ ............ ........... ............ ............ ............ ........... ............ .... (41%) in patients with aortic stenosis with or without aortic insufficiency. This finding suggests that patients with aortic valve disease, and aortic stenosis in particular, have a limited capacity to tolerate the negative inotropic effects of acute myocardial infarction.
Strengths and limitations of current epidemiology of heart valve disease
Nkomo et al. 6 have provided information about the prevalence and age distribution of valvular heart disease from a randomly selected population of patients from Rochester, USA. They found that the prevalence of heart valve disease was strongly influenced by age, with the cumulative prevalence of aortic and mitral valve disease ranging from 0.7% in adults aged 18-44 to 13.2% in the elderly (age ≥ 75 years). Although mitral insufficiency was the commonest valve pathology, aortic stenosis was also common, particularly in the elderly. 6 The only other contemporary epidemiological study is the EuroHeart Survey 5 which was a prospective multicentre European study of planned and unplanned hospital visits by patients with a diagnosis of aortic and mitral valve disease (April -July 2001). Our study is different since we have provided a population-level analysis in a much larger cohort during a 10-year period.
Treatment of aortic valve disease
Increasingly, heart valve disease is being recognized as a public health concern with requirements for healthcare planning. 15 The treatment of heart valve disease can be difficult. Drug therapies alleviate symptoms but do not modify prognosis. 7, 8, 16 Aortic valve replacement improves prognosis 17 and the proportion of patients .75 years undergoing valve replacement has steadily increased in the UK since 1999. 18 Therefore, because of increasing longevity, the number of aortic valve replacements is projected to rise markedly in the coming years. Many elderly persons with heart valve disease are unsuitable for surgical valve replacement 9, 10, 18, 19 and this area of unmet need has stimulated new therapeutic approaches. Transcatheter aortic valve implantation is a promising emerging treatment for patients who are unsuitable for surgery. 9, 10, 20, 21 The PARTNER trial demonstrated that in patients with inoperable aortic stenosis, TAVI reduced all-cause mortality and hospitalizations compared with usual care 9 confirming that TAVI represents an alternative to surgical aortic valve replacement in high-risk patients.
Limitations of the current study
We accept that the data on incidence of aortic valve disease may be affected by detection bias. However, we believe the distinct trends over time for each aortic valve entity are correct and cannot simply be explained by increased detection such as through improved access to echocardiography, since uniform increases in the incidences of different types of aortic valve disease did not occur. For example, the number of first hospitalizations with a diagnosis of aortic stenosis increased markedly over time, whereas the number of hospitalizations with a diagnosis of aortic insufficiency remained reasonably constant. We accept that a small minority of patients with undisclosed bicuspid aortic valve disease may have been included, although imaging typically detects this pathology. We also accept that coding of some clinical characteristics, such as hypertension, may be incomplete.
The management of heart valve disease in Scotland may differ in some ways (e.g. concomitant revascularization rates with valve surgery) compared with other countries. However, the prognostic models in our study will be relevant to populations elsewhere, since our data are derived from the full spectrum of socioeconomic backgrounds.
In conclusion, we report the epidemiology and temporal trends of different types of acquired aortic valve disease at a population level. The incidence of aortic stenosis has increased in Scotland in recent years. Probably because of increased longevity in general, aortic stenosis will become an increasingly important public health problem.
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